PATENT CLAIM ANALYSIS

Application Number: 15922405
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "171000"]

Abstract:
Disclosed herein are pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione. Also disclosed are methods of treating diseases and/or conditions associated with a cancer, such as prostate cancer with such pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione. The disclosed pharmaceutical compositions may provide improved dosage for oral administration to patients in the clinic. The disclosed pharmaceutical compositions may provide improved stability and/or shelf life.

Claim (Index 27):
The pharmaceutical composition of  claim 26 , wherein when Compound I is dissolved in the pharmaceutically acceptable carrier at a temperature between 25\u00b0 C. and 37\u00b0 C., the resulting mixture is a liquid having a viscosity between 20-250 milliPascal seconds (mPa\u00b7s).

Metadata:
- Claim Count in Document: 35.0
- Percentile: 90.0
- Lexical Diversity: 1.58974
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12374828', '14434060', '10107537', '13908507', '13752330']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.798448296050808
- 35 USC 102 Novelty (BERT): 0.5186648841372585
- Combined Prediction Score: 0.7704699548594531
- Mean Citation Score: 280.949156
- Max Citation Score: 290.9978
- Similarity Product: 179.35879947578908

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test